Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry.
David BalazPhilip Erick Wikman-JorgensenVicente Giner GalvañManuel Rubio-RivasBorja de Miguel CampoMariam Noureddine LópezJuan Francisco López CaleyaRicardo Gómez HuelgasPaula María Pesqueira FontánManuel Méndez BailónMar Fernández-GarcésAna Fernández CruzGema María García GarcíaNicolás RhymanLuis Corral GudinoAquiles Lozano Rodríguez-MancheñoMaría Navarro De La ChicaAndrea Torregrosa GarcíaJosé Nicolás AlcaláPablo Díaz JiménezLeticia Esther Royo TralleroPere Comas CasanovaJesús Millán Núñez-CortésJosé-Manuel Casas-Rojonull On Behalf Of The Semi-Covid-NetworkPublished in: Journal of clinical medicine (2021)
Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%.